|
Date / Time
|
Studies & Bills
|
Location
|
|
November 8, 2012
10:29 AM
|
- Study on prescription pharmaceuticals in Canada
- Françoise Baylis, Professor and Canada Research Chair, Faculty of Medicine, Dalhousie University (As an individual)
- Trudo Lemmens, Scholl Chair in Health Law and Policy, Faculty of Law, University of Toronto (As an individual)
- Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University (As an individual)
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 7, 2012
4:14 PM
|
- Study on prescription pharmaceuticals in Canada
- John G. Abbott, Chief Executive Officer (Health Council of Canada)
- Sylvia Hyland, Vice-President (Institute for Safe Medication Practices Canada)
- Mike Sheridan, Chief Operating Officer (Canada Health Infoway)
- Ingrid Sketris, Councillor (Health Council of Canada)
- Jennifer Zelmer, Senior Vice-President, Clinical Adoption and Innovation (Canada Health Infoway)
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 1, 2012
10:29 AM
|
- S-204, National Strategy for Chronic Cerebrospinal Venous Insufficiency Act
- Dr. Andreas Laupacis, Executive Director, Li Ka Shing Knowledge Institute, St.Michael's Hospital (As an individual)
- Dr. Paolo Zamboni, Director, Vascular Diseases Centre, University of Ferrara, Italy (As an individual)
- Dr. Robert Zivadinov, Director, Buffalo Neuroimaging Analysis Centre (As an individual)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 31, 2012
4:21 PM
|
- Study on prescription pharmaceuticals in Canada
- Dr. Gerald Dal Pan, Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (United States Food and Drug Administration)
- Dr. Robert Temple, Deputy Center Director for Clinical Science, Center for Drug Evaluation and Research (United States Food and Drug Administration)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 25, 2012
10:29 AM
|
- Study on prescription pharmaceuticals in Canada
- Andrew Casey, President and Chief Executive Officer (BIOTECanada)
- Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc. (Canadian Generic Pharmaceutical Association)
- Loretta Del Bosco, Director, Regulatory Affairs, Quality Assurance and Operations, Abbott Canada (BIOTECanada)
- Stan Glezer, Vice-President, Evidence, Value and Access, Sanofi (Rx&D)
- Ken Hughes, Vice-President, Scientific and Regulatory Affairs (Rx&D)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 24, 2012
4:18 PM
|
- Study on prescription pharmaceuticals in Canada
- Carole Bouchard, Executive Director (National Association of Pharmacy Regulatory Authorities)
- Barbara Mildon, President (Canadian Nurses Association)
- Dr. Anna Reid, President (Canadian Medical Association)
- Millicent Toombs, Director, Public Health Department (Canadian Medical Association)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 18, 2012
10:29 AM
|
- Consideration of a draft agenda (future business)
- S-204, National Strategy for Chronic Cerebrospinal Venous Insufficiency Act
- Bernhard Juurlink, Director (National CCSVI Society)
- Dr. Barry Rubin, Medical Director, Peter Munk Cardiac Centre, University Health Network (As an individual)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 17, 2012
4:18 PM
|
- Study on prescription pharmaceuticals in Canada
- Dr. Alain Beaudet, President (Canadian Institutes of Health Research)
- Janet Currie, Representative (Psychiatric Medication Awareness Group)
- Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network (Canadian Institutes of Health Research)
- Terence Young, Member of Parliament for Oakville and founder of Drug Safety Canada
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 4, 2012
10:29 AM
|
- S-204, National Strategy for Chronic Cerebrospinal Venous Insufficiency Act
- Dr. Alain Beaudet, President (Canadian Institutes of Health Research)
- Jean-Marie Berthelot, Vice-President, Programs (Canadian Institute for Health Information)
- Ann Chapman, Manager, Canadian Multiple Sclerosis Monitoring System (Canadian Institute for Health Information)
- The Honourable Senator Jane Cordy, sponsor of the bill
- Kirsty Duncan, Member of Parliament for Etobicoke-North
- Rodney Ghali, A/Senior Director, Partnerships and Strategies Division (Public Health Agency of Canada)
- John Wright, President and CEO (Canadian Institute for Health Information)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 3, 2012
4:13 PM
|
- Study on prescription pharmaceuticals in Canada
- Dr. Marc Berthiaume, Director, Marketed Pharmaceuticals and Medical Devices Bureau (HPFB) (Health Canada)
- Louise Dubé, Principal (Office of the Auditor General of Canada)
- Paul Glover, Assistant Deputy Minister, Health Products and Food Branch (HPFB) (Health Canada)
- Neil Maxwell, Assistant Auditor General (Office of the Auditor General of Canada)
|
Room 2, Victoria Building
140 Wellington Street
|
|